Furthermore, in a xenograft and azoxymethane-induced colon cancer model, MAGL inhibition led to downregulation of VEGF and FGF-2, thus justifying the antiangiogenic and antimetastatic effect determined by MAGL inhibition. This evidence concerns the gene MGLL and malignant colon neoplasm.